Analyst Erin Wilson works at MORGAN STANLEY and is focused on the Healthcare sector with 578 price targets and ratings documented since 2014 spanning on 29 stocks. Previously, Erin Wilson worked at CREDIT SUISSE. Analyst's average stock valuation to be materialised ratio is 73.12% with an average time for price targets to be met of 177.62 days.
Most recent stock forecast was given on CVS, CVS Health Corporation at 23-Nov-2022.
Erin Wilson best performing recommendations are on MRVI.
The best stock recommendation documented was for MRVI at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside